2024 Residents Bowl Team Name Contest
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Take this survey powered by surveymonkey.com. Create your own surveys for free.
DD01 is a long-acting dual agonist of glucagon-like peptide-1 and glucagon receptors.
Neal D. Shore, MD, shares what he’s most looking forward to at this year’s American Urological Association Annual Meeting.
Adding the radionuclide therapy ¹⁷⁷Lu-PSMA-617 to enzalutamide improved outcomes in patients with treatment-naïve mCRPC in a phase 2 trial.
Topic: Implementation Science in Urologic Oncology: Translating Evidence into Practice Symposium Goal: To introduce Implementation Science to those new to the field, highlight how implementation…
Alicia Morgans presents a meta-analysis, undertaken with colleagues, analyzing 14 phase three trials on treatment intensification in metastatic hormone-sensitive prostate cancer. The study scrutinizes outcomes…
Investigators assessed the monosodium urate burden using 2 ultrasound scoring systems among patients with gout and compared their ability to predict flares.
The largest gathering of residents at the Annual Meeting, this year’s Residents Forum program will feature motivating speakers and interactive discussions with experts in the…
The AUA invites the global urologic community to the 119th AUA Annual Meeting in the dynamic city of San Antonio, TX!
Even after adjusting for socioeconomic factors, environmental factors independently tied to higher risk
UroViu’s portable and versatile disposable cystoscopy platform delivers consistent performance, on par with reusable scopes, advancing clinical care, and limiting disposable waste. The benefit of…